Travere Therapeutics Cash from Investing (TTM) Insights

Travere Therapeutics Inc (TVTX)

5.28 -0.17 (-3.12%) USD | NASDAQ | Apr 25, 12:10

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	55.78M
September 30, 2023	36.02M
June 30, 2023	-87.21M
March 31, 2023	-102.76M
December 31, 2022	-32.55M
September 30, 2022	11.52M
June 30, 2022	33.96M
March 31, 2022	1.248M
December 31, 2021	-137.62M
September 30, 2021	-270.50M
June 30, 2021	-346.19M
March 31, 2021	-206.58M
December 31, 2020	-61.33M
September 30, 2020	65.76M
June 30, 2020	113.40M
March 31, 2020	70.83M
December 31, 2019	19.86M
September 30, 2019	-30.52M
June 30, 2019	-196.53M
March 31, 2019	-193.85M
December 31, 2018	-203.29M

Date	Value
September 30, 2018	-154.59M
June 30, 2018	4.765M
March 31, 2018	20.63M
December 31, 2017	45.60M
September 30, 2017	76.18M
June 30, 2017	72.31M
March 31, 2017	24.25M
December 31, 2016	10.37M
September 30, 2016	-120.56M
June 30, 2016	-62.29M
March 31, 2016	-59.55M
December 31, 2015	-80.60M
September 30, 2015	21.83M
June 30, 2015	-32.46M
March 31, 2015	-36.96M
December 31, 2014	-37.26M
September 30, 2014	-37.97M
June 30, 2014	-41.26M
March 31, 2014	-35.21M
December 31, 2013	-5.406M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-346.19M

Minimum

Jun 2021

113.40M

Maximum

Jun 2020

-55.97M

Average

-30.52M

Median

Sep 2019

Cash from Investing (TTM) Benchmarks